Feasibility study of oral cyclophosphamide salvage therapy for the treatment of heavily pretreated patients with recurrent epithelial ovarian cancer

被引：0
|
作者：
Yoh Watanabe
Tomomaro Etoh
Eiji Koike
Yoshiaki Mizuno
Wei-Min Wang
Hiroshi Hoshiai
机构：
[1] Kinki University School of Medicine,Department of Obstetrics and Gynecology
来源：
International Journal of Clinical Oncology | 2010年 / 15卷
关键词：
Recurrent ovarian cancer; Salvage therapy; Cyclophosphamide;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：468 / 471
页数：3
相关论文
共 50 条
  • [31] VDTPACE As Salvage Therapy For Heavily Pretreated MM Patients
    Buda, Gabriele
    Orciuolo, Enrico
    Galimberti, Sara
    Ghio, Francesco
    Petrini, Mario
    BLOOD, 2013, 122 (21)
  • [32] Oral altretamine used as salvage therapy in recurrent ovarian cancer
    Chan, JK
    Loizzi, V
    Manetta, A
    Berman, ML
    GYNECOLOGIC ONCOLOGY, 2004, 92 (01) : 368 - 371
  • [33] Single agent trabectedin in heavily pretreated patients with recurrent ovarian cancer (ROC).
    Boumedien, Feriel
    Adam, Jean-Philippe
    Akkour, Khalid
    LeTarte, Nathalie
    Provencher, Diane M.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [34] Oral cyclophosphamide in recurrent ovarian cancer
    Handolias, Despina
    Quinn, Michael
    Foo, Serene
    Mileshkin, Linda
    Grant, Peter
    Dutu, Gaelle
    Rischin, Danny
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 (01) : E154 - E160
  • [35] Pegylated liposomal doxorubicin (PLD) in heavily pretreated epithelial ovarian cancer patients
    Gorumlu, Gurbuz
    Kucukzeybek, Yuksel
    Karabulut, Bulent
    Terek, Mustafa C.
    Uslu, Ruchan
    Sanli, Ulus A.
    Akman, Levent
    Ozsaran, Aydin
    Dikmen, Yilmaz
    Goker, Erdem
    ANNALS OF ONCOLOGY, 2006, 17 : 172 - 172
  • [36] A phase II study of irofulven in women with recurrent and heavily pretreated ovarian cancer
    Seiden, MV
    Gordon, AN
    Bodurka, DC
    Matulonis, UA
    Penson, RT
    Reed, E
    Alberts, DS
    Weems, G
    Cullen, M
    McGuire, WP
    GYNECOLOGIC ONCOLOGY, 2006, 101 (01) : 55 - 61
  • [37] Selection of candidates for oral etoposide salvage chemotherapy in heavily pretreated breast cancer patients
    Jagodic, M
    Cufer, T
    Zakotnik, B
    Cervek, J
    ANTI-CANCER DRUGS, 2001, 12 (03) : 199 - 204
  • [38] Phase II study of trabectedin in pretreated patients with recurrent epithelial ovarian cancer (REOC)
    Marinaccio, Marco
    Mele, Emilia
    Lorusso, Vito
    Fumarulo, Valeria Vincenza
    Sozzi, Fausta
    Cicinelli, Ettore
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [39] Influence of germline BRCA mutation on response to oral cyclophosphamide in relapsed heavily pretreated ovarian cancer.
    Spiliopoulou, Pavlina
    Zubairi, Ishtiaq
    Gibson, Sarah
    Brown, Jennifer
    McNeish, Iain
    Glasspool, Ros
    CLINICAL CANCER RESEARCH, 2018, 24 (15) : 82 - 83
  • [40] Oral and intravenous treosulfan in heavily pretreated elderly patients with recurrent ovarian cancer. Safety analysis of a prospective multicenter study of the NOGGO
    Mahner, S.
    Oskay-Oezcelik, G.
    Heidrich-Lorsbach, E.
    Mueller, L.
    Fuxius, S.
    Sommer, H.
    Klare, P.
    Belau, A.
    Ullrich, D.
    Heuser, T.
    Jaenicke, F.
    Lichtenegger, W.
    Sehouli, J.
    ONKOLOGIE, 2010, 33 : 167 - 167
12345